Cosmax Nbt, Inc (222040) Fair Value & Analysis
Consumer Defensive · KR · Market cap 138B KRW
Fair value as of: Jun 24, 2026
Analysis
Cosmax Nbt, Inc (222040) currently trades at 5,720 KRW, while our model-based Fair Value estimate is 10,649 KRW — implying the stock looks roughly 86.2% undervalued today. We read business quality at 93/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Cosmax Nbt, Inc. operates as a health functional food company in South Korea and internationally. It also provides original design and original brand manufacturing services. In addition, the company offers cosmetics, medicines, and medical supplies. It offers its products in tablets, capsules, liquid, and powder supplement form of dosages. The company serves its products through business to business, distribution companies, pharmaceutical and food companies, networks, and online channels. Cosmax Nbt, Inc. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Cosmax Nbt, Inc (222040) undervalued?
What is the fair value of 222040?
What is the quality score of 222040?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.